| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | FINANCIAL OFFICER, (PFO & PAO) | Stock Options (right to buy) | 50,000 | $76,000 | $1.52 | 10 Feb 2023 | Direct |
| Bellerophon Therapeutics, Inc. | FINANCIAL OFFICER, (PFO & PAO) | Common Stock | 12,470 | $1,294 | $0.1038 | 09 Dec 2022 | Direct |
| Bellerophon Therapeutics, Inc. | FINANCIAL OFFICER, (PFO & PAO) | Restricted Stock Units | 18,000 | 09 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics, Inc. | 10 Feb 2023 | 1 | $76,000 | 4 | FINANCIAL OFFICER, (PFO & PAO) | 14 Feb 2023, 15:46 |
| BLPH | Bellerophon Therapeutics, Inc. | 09 Dec 2022 | 3 | -$5,143 | 4 | FINANCIAL OFFICER, (PFO & PAO) | 13 Dec 2022, 16:25 |
| BLPH | Bellerophon Therapeutics, Inc. | 26 Jan 2022 | 1 | $0 | 4 | FINANCIAL OFFICER, (PFO & PAO) | 28 Jan 2022, 15:30 |
| BLPH | Bellerophon Therapeutics, Inc. | 30 Sep 2021 | 0 | $0 | 3 | Controller, (PFO & PAO) | 08 Oct 2021, 17:26 |